SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    R. Moore, A. Spinhirne, M. J. Lai, S. Preisser, Y. Li, T. Kang, L. Bleris, CRISPR-based self-cleaving mechanism for controllable gene delivery in human cells, Nucleic Acids Research, 2015, 43, 2, 1297

    CrossRef

  2. 2
    Hong Fang Lu, Chou Chai, Tze Chiun Lim, Meng Fatt Leong, Jia Kai Lim, Shujun Gao, Kah Leong Lim, Andrew C.A. Wan, A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells, Biomaterials, 2014, 35, 9, 2816

    CrossRef

  3. 3
    Jun Li, Wei Song, Guangjin Pan, Jun Zhou, Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells, Journal of Hematology & Oncology, 2014, 7, 1, 50

    CrossRef

  4. 4
    Kejin Hu, All Roads Lead to Induced Pluripotent Stem Cells: The Technologies of iPSC Generation, Stem Cells and Development, 2014, 23, 12, 1285

    CrossRef

  5. 5
    Katarzyna Skowron, Marcin Tomsia, Piotr Czekaj, An Experimental Approach to the Generation of Human Embryonic Stem Cells Equivalents, Molecular Biotechnology, 2014, 56, 1, 12

    CrossRef

  6. 6
    E. Varga, C. Nemes, R.P. Davis, O. Ujhelly, N. Klincumhom, Z. Polgar, S. Muenthaisong, M.K. Pirity, A. Dinnyes, Generation of transgene-free mouse induced pluripotent stem cells using an excisable lentiviral system, Experimental Cell Research, 2014, 322, 2, 335

    CrossRef

  7. 7
    Weida Li, Mio Nakanishi, Adrian Zumsteg, Matthew Shear, Christopher Wright, Douglas A Melton, Qiao Zhou, In vivo reprogramming of pancreatic acinar cells to three islet endocrine subtypes, eLife, 2014, 3,

    CrossRef

  8. 8
    Margherita Ruggieri, Giulietta Riboldi, Simona Brajkovic, Monica Bucchia, Nereo Bresolin, Giacomo P. Comi, Stefania Corti, Induced neural stem cells: Methods of reprogramming and potential therapeutic applications, Progress in Neurobiology, 2014, 114, 15

    CrossRef

  9. 9
    Yigang Wang, Myocardial Reprogramming Medicine: The Development, Application, and Challenge of Induced Pluripotent Stem Cells, New Journal of Science, 2014, 2014, 1

    CrossRef

  10. 10
    Sebastian Diecke, Seung Min Jung, Jaecheol Lee, Ji Hyeon Ju, Recent technological updates and clinical applications of induced pluripotent stem cells, The Korean Journal of Internal Medicine, 2014, 29, 5, 547

    CrossRef

  11. 11
    Yudan Fang, Xiuli Gong, Miao Xu, Fanyi Zeng, Jingzhi Zhang, A self-deletion lentiviral vector to reduce the risk of replication-competent virus formation, The Journal of Gene Medicine, 2013, 15, 2
  12. 12
    Majad Khan, Karthikeyan Narayanan, Hongfang Lu, Yang Choo, Chan Du, Nikken Wiradharma, Yi-Yan Yang, Andrew C.A. Wan, Delivery of reprogramming factors into fibroblasts for generation of non-genetic induced pluripotent stem cells using a cationic bolaamphiphile as a non-viral vector, Biomaterials, 2013, 34, 21, 5336

    CrossRef

  13. 13
    Mitsuyoshi Imaizumi, Yukio Nomoto, Takashi Sugino, Koshi Otsuki, Koichi Omori, Implantation site-dependent differences for tracheal regeneration with induced pluripotent stem cells (iPS cells), Acta Oto-laryngologica, 2013, 133, 4, 405

    CrossRef

  14. 14
    Maria Mercedes Segura, Mathias Mangion, Bruno Gaillet, Alain Garnier, New developments in lentiviral vector design, production and purification, Expert Opinion on Biological Therapy, 2013, 13, 7, 987

    CrossRef

  15. 15
    Adrian Kee Keong Teo, Amy J. Wagers, Rohit N. Kulkarni, New Opportunities: Harnessing Induced Pluripotency for Discovery in Diabetes and Metabolism, Cell Metabolism, 2013, 18, 6, 775

    CrossRef

  16. 16
    =Daisuke Araki, =Yoshimi Kawamura, =Kunimichi Niibe, =Sadafumi Suzuki, =Satoru Morikawa, =Yo Mabuchi, =Taneaki Nakagawa, =Hideyuki Okano, =Yumi Matsuzaki, Primary evaluation of induced pluripotent stem cells using flow cytometry, Inflammation and Regeneration, 2013, 33, 1, 003

    CrossRef

  17. 17
    Caterina Bianco, Nadia P. Castro, Christina Baraty, Kelly Rollman, Natalie Held, Maria Cristina Rangel, Hideaki Karasawa, Monica Gonzales, Luigi Strizzi, David S. Salomon, Regulation of human Cripto-1 expression by nuclear receptors and DNA promoter methylation in human embryonal and breast cancer cells, Journal of Cellular Physiology, 2013, 228, 6
  18. 18
    Juan A. Bernal, RNA-Based Tools for Nuclear Reprogramming and Lineage-Conversion: Towards Clinical Applications, Journal of Cardiovascular Translational Research, 2013, 6, 6, 956

    CrossRef

  19. 19
    Cesar A. Sommer, Gustavo Mostoslavsky, The evolving field of induced pluripotency: Recent progress and future challenges, Journal of Cellular Physiology, 2013, 228, 2
  20. 20
    Garry A Luke, Martin D Ryan, The protein coexpression problem in biotechnology and biomedicine: virus 2A and 2A-like sequences provide a solution, Future Virology, 2013, 8, 10, 983

    CrossRef

  21. 21
    Stefano Pietronave, Maria Prat, Advances and applications of induced pluripotent stem cells, Canadian Journal of Physiology and Pharmacology, 2012, 90, 3, 317

    CrossRef

  22. 22
    Mahendra S. Rao, Nasir Malik, Assessing iPSC reprogramming methods for their suitability in translational medicine, Journal of Cellular Biochemistry, 2012, 113, 10
  23. 23
    Margaret A. Young, David E. Larson, Chiao-Wang Sun, Daniel R. George, Li Ding, Christopher A. Miller, Ling Lin, Kevin M. Pawlik, Ken Chen, Xian Fan, Heather Schmidt, Joelle Kalicki-Veizer, Lisa L. Cook, Gary W. Swift, Ryan T. Demeter, Michael C. Wendl, Mark S. Sands, Elaine R. Mardis, Richard K. Wilson, Tim M. Townes, Timothy J. Ley, Background Mutations in Parental Cells Account for Most of the Genetic Heterogeneity of Induced Pluripotent Stem Cells, Cell Stem Cell, 2012, 10, 5, 570

    CrossRef

  24. 24
    Gustavo Mostoslavsky, Concise Review: The Magic Act of Generating Induced Pluripotent Stem Cells: Many Rabbits in the Hat, STEM CELLS, 2012, 30, 1
  25. 25
    A. Margariti, B. Winkler, E. Karamariti, A. Zampetaki, T.-n. Tsai, D. Baban, J. Ragoussis, Y. Huang, J.-D. J. Han, L. Zeng, Y. Hu, Q. Xu, Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels, Proceedings of the National Academy of Sciences, 2012, 109, 34, 13793

    CrossRef

  26. 26
    Rahul S. Deshmukh, Krisztián A Kovács, András Dinnyés, Drug Discovery Models and Toxicity Testing Using Embryonic and Induced Pluripotent Stem-Cell-Derived Cardiac and Neuronal Cells, Stem Cells International, 2012, 2012, 1

    CrossRef

  27. 27
    Xianmei Meng, Amanda Neises, Rui-Jun Su, Kimberly J Payne, Linda Ritter, Daila S Gridley, Jun Wang, Matilda Sheng, K-H William Lau, David J Baylink, Xiao-Bing Zhang, Efficient Reprogramming of Human Cord Blood CD34+ Cells Into Induced Pluripotent Stem Cells With OCT4 and SOX2 Alone, Molecular Therapy, 2012, 20, 2, 408

    CrossRef

  28. 28
    S. Miyazaki, H. Yamamoto, N. Miyoshi, H. Takahashi, Y. Suzuki, N. Haraguchi, H. Ishii, Y. Doki, M. Mori, Emerging Methods for Preparing iPS Cells, Japanese Journal of Clinical Oncology, 2012, 42, 9, 773

    CrossRef

  29. 29
    Luigi Warren, Yuhui Ni, Jiwu Wang, Xirong Guo, Feeder-Free Derivation of Human Induced Pluripotent Stem Cells with Messenger RNA, Scientific Reports, 2012, 2,

    CrossRef

  30. 30
    M Ian Phillips, Gene, Stem Cell, and Future Therapies for Orphan Diseases, Clinical Pharmacology & Therapeutics, 2012, 92, 2
  31. 31
    Bhavita Walia, Neeraj Satija, Rajendra Prashad Tripathi, Gurudutta U. Gangenahalli, Induced Pluripotent Stem Cells: Fundamentals and Applications of the Reprogramming Process and its Ramifications on Regenerative Medicine, Stem Cell Reviews and Reports, 2012, 8, 1, 100

    CrossRef

  32. 32
    Aurélie Bedel, Miguel Taillepierre, Véronique Guyonnet-Duperat, Eric Lippert, Pierre Dubus, Sandrine Dabernat, Thibaud Mautuit, Bruno Cardinaud, Catherine Pain, Benoît Rousseau, Magalie Lalanne, Cécile Ged, Yann Duchartre, Emmanuel Richard, Hubert de Verneuil, François Moreau-Gaudry, Metabolic Correction of Congenital Erythropoietic Porphyria with iPSCs Free of Reprogramming Factors, The American Journal of Human Genetics, 2012, 91, 1, 109

    CrossRef

  33. 33
    Peter J. Amos, Esra Cagavi Bozkulak, Yibing Qyang, Methods of Cell Purification: A Critical Juncture for Laboratory Research and Translational Science, Cells Tissues Organs, 2012, 195, 1-2, 26

    CrossRef

  34. 34
    Suying Cao, Kyle Loh, Yangli Pei, Wei Zhang, Jianyong Han, Overcoming barriers to the clinical utilization of iPSCs: reprogramming efficiency, safety and quality, Protein & Cell, 2012, 3, 11, 834

    CrossRef

  35. 35
    Jai-Yoon Sul, Tae Kyung Kim, Jae Hee Lee, James Eberwine, Perspectives on cell reprogramming with RNA, Trends in Biotechnology, 2012, 30, 5, 243

    CrossRef

  36. 36
    Benjamin Groß, Erik Pittermann, Dirk Reinhardt, Tobias Cantz, Jan-Henning Klusmann, Prospects and Challenges of Reprogrammed Cells in Hematology and Oncology, Pediatric Hematology-Oncology, 2012, 29, 6, 507

    CrossRef

  37. 37
    Sean Palecek, Stem Cell Engineering, 2012,

    CrossRef

  38. 38
    Young-Doug Sohn, Ji Woong Han, Young-sup Yoon, Genetics of Stem Cells, Part A, 2012,

    CrossRef

  39. 39
    Mei I. Lai, Wai Yeng Wendy-Yeo, Rajesh Ramasamy, Norshariza Nordin, Rozita Rosli, Abhi Veerakumarasivam, Syahril Abdullah, Advancements in reprogramming strategies for the generation of induced pluripotent stem cells, Journal of Assisted Reproduction and Genetics, 2011, 28, 4, 291

    CrossRef

  40. You have free access to this content40
    Christopher Baum, Ute Modlich, Gudrun Göhring, Brigitte Schlegelberger, Concise Review: Managing Genotoxicity in the Therapeutic Modification of Stem Cells, STEM CELLS, 2011, 29, 10
  41. 41
    Gabriel Kun Yung Wong, Andrew T. Chiu, Gene therapy, gene targeting and induced pluripotent stem cells: Applications in monogenic disease treatment, Biotechnology Advances, 2011, 29, 1, 1

    CrossRef

  42. 42
    Eirini P Papapetrou, Michel Sadelain, Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector, Nature Protocols, 2011, 6, 9, 1251

    CrossRef

  43. 43
    Clara Cheong, Patricia Lon Ng, Rhonda Ponnampalam, Heng-Hang Tsai, Guillaume Bourque, Thomas Lufkin, In silico tandem affinity purification refines an Oct4 interaction list, Stem Cell Research & Therapy, 2011, 2, 3, 26

    CrossRef

  44. 44
    Ji Woong Han, Young-sup Yoon, Induced Pluripotent Stem Cells: Emerging Techniques for Nuclear Reprogramming, Antioxidants & Redox Signaling, 2011, 15, 7, 1799

    CrossRef

  45. 45
    Boro Dropulić, Lentiviral Vectors: Their Molecular Design, Safety, and Use in Laboratory and Preclinical Research, Human Gene Therapy, 2011, 22, 6, 649

    CrossRef

  46. 46
    Ritchie Ho, Constantinos Chronis, Kathrin Plath, Mechanistic insights into reprogramming to induced pluripotency, Journal of Cellular Physiology, 2011, 226, 4
  47. 47
    Nicole M. Kane, Qingzhong Xiao, Andrew H. Baker, Zhenling Luo, Qingbo Xu, Costanza Emanueli, Pluripotent stem cell differentiation into vascular cells: A novel technology with promises for vascular re(generation), Pharmacology & Therapeutics, 2011, 129, 1, 29

    CrossRef

  48. 48
    Zhuo Zhang, Amanda Jones, Chiao-Wang Sun, Chao Li, Chia-Wei Chang, Heui-Yun Joo, Qian Dai, Matthew R. Mysliwiec, Li-Chen Wu, Yahong Guo, Wei Yang, Kaimao Liu, Kevin M. Pawlik, Hediye Erdjument-Bromage, Paul Tempst, Youngsook Lee, Jinrong Min, Tim M. Townes, Hengbin Wang, PRC2 Complexes with JARID2, MTF2, and esPRC2p48 in ES Cells to Modulate ES Cell Pluripotency and Somatic Cell Reprograming, STEM CELLS, 2011, 29, 2
  49. 49
    Kathrin Plath, William E. Lowry, Progress in understanding reprogramming to the induced pluripotent state, Nature Reviews Genetics, 2011, 12, 4, 253

    CrossRef

  50. 50
    Feng Zhang, Fudiman Citra, Dong-An Wang, Prospects of Induced Pluripotent Stem Cell Technology in Regenerative Medicine, Tissue Engineering Part B: Reviews, 2011, 17, 2, 115

    CrossRef

  51. 51
    Orit Harari-Steinberg, Oren Pleniceanu, Benjamin Dekel, Selecting the optimal cell for kidney regeneration, Organogenesis, 2011, 7, 2, 123

    CrossRef

  52. 52
    Marisa Karow, Christopher L. Chavez, Alfonso P. Farruggio, Jonathan M. Geisinger, Annahita Keravala, W. Edward Jung, Feng Lan, Joseph C. Wu, Yanru Chen-Tsai, Michele P. Calos, Site-Specific Recombinase Strategy to Create Induced Pluripotent Stem Cells Efficiently with Plasmid DNA, STEM CELLS, 2011, 29, 11
  53. 53
    I. Wilmut, G. Sullivan, I. Chambers, The evolving biology of cell reprogramming, Philosophical Transactions of the Royal Society B: Biological Sciences, 2011, 366, 1575, 2183

    CrossRef

  54. 54
    Elena S. Philonenko, Maria V. Shutova, Ilya V. Chestkov, Maria A. Lagarkova, Sergey L. Kiselev, 2011,

    CrossRef

  55. 55
    Maureen L. Condic, Mahendra Rao, Alternative Sources of Pluripotent Stem Cells: Ethical and Scientific Issues Revisited, Stem Cells and Development, 2010, 19, 8, 1121

    CrossRef

  56. 56
    L Anastasia, G Pelissero, B Venerando, G Tettamanti, Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine, Cell Death and Differentiation, 2010, 17, 8, 1230

    CrossRef

  57. 57
    Christopher N Mayhew, James M Wells, Converting human pluripotent stem cells into β-cells: recent advances and future challenges, Current Opinion in Organ Transplantation, 2010, 15, 1, 54

    CrossRef

  58. 58
    Atara Novak, Ronit Shtrichman, Igal Germanguz, Hanna Segev, Naama Zeevi-Levin, Bettina Fishman, Ya-el Mandel, Lili Barad, Hagit Domev, Darrell Kotton, Gustavo Mostoslavsky, Ofer Binah, Joseph Itskovitz-Eldor, Enhanced Reprogramming and Cardiac Differentiation of Human Keratinocytes Derived from Plucked Hair Follicles, Using a Single Excisable Lentivirus, Cellular Reprogramming (Formerly "Cloning and Stem Cells"), 2010, 12, 6, 665

    CrossRef

  59. 59
    Dominic G. Rothwell, Rachel Crossley, John S. Bridgeman, Victoria Sheard, Yining Zhang, Tyson V. Sharp, Robert E. Hawkins, David E. Gilham, Tristan R. McKay, Functional Expression of Secreted Proteins from a Bicistronic Retroviral Cassette Based on Foot-and-Mouth Disease Virus 2A Can Be Position Dependent, Human Gene Therapy, 2010, 21, 11, 1631

    CrossRef

  60. 60
    Gabriel Kun Yung Wong, Andrew T. Chiu, Gene therapy, gene targeting and induced pluripotent stem cells: Applications in monogenic disease treatment, Biotechnology Advances, 2010, 28, 6, 715

    CrossRef

  61. 61
    Yuehong Wu, Yong Zhang, Anuja Mishra, Suzette D. Tardif, Peter J. Hornsby, Generation of induced pluripotent stem cells from newborn marmoset skin fibroblasts, Stem Cell Research, 2010, 4, 3, 180

    CrossRef

  62. 62
    Luigi Warren, Philip D. Manos, Tim Ahfeldt, Yuin-Han Loh, Hu Li, Frank Lau, Wataru Ebina, Pankaj K. Mandal, Zachary D. Smith, Alexander Meissner, George Q. Daley, Andrew S. Brack, James J. Collins, Chad Cowan, Thorsten M. Schlaeger, Derrick J. Rossi, Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA, Cell Stem Cell, 2010, 7, 5, 618

    CrossRef

  63. 63
    Pablo Juan Ross, Steven Thomas Suhr, Ramon Maria Rodriguez, Eun-Ah Chang, Kai Wang, Kannika Siripattarapravat, Tak Ko, Jose Bernardo Cibelli, Human-Induced Pluripotent Stem Cells Produced Under Xeno-Free Conditions, Stem Cells and Development, 2010, 19, 8, 1221

    CrossRef

  64. 64
    Timothy J. Nelson, Almudena Martinez-Fernandez, Andre Terzic, Induced pluripotent stem cells: developmental biology to regenerative medicine, Nature Reviews Cardiology, 2010,

    CrossRef

  65. 65
    Mark H. Chin, Matteo Pellegrini, Kathrin Plath, William E. Lowry, Molecular Analyses of Human Induced Pluripotent Stem Cells and Embryonic Stem Cells, Cell Stem Cell, 2010, 7, 2, 263

    CrossRef

  66. 66
    Eyayu Belay, Janka Mátrai, Abel Acosta-Sanchez, Ling Ma, Mattia Quattrocelli, Lajos Mátés, Pau Sancho-Bru, Martine Geraerts, Bing Yan, Joris Vermeesch, Melvin Yesid Rincón, Ermira Samara-Kuko, Zoltán Ivics, Catherine Verfaillie, Maurilio Sampaolesi, Zsuzsanna Izsvák, Thierry VandenDriessche, Marinee K. L. Chuah, Novel Hyperactive Transposons for Genetic Modification of Induced Pluripotent and Adult Stem Cells: A Nonviral Paradigm for Coaxed Differentiation, STEM CELLS, 2010, 28, 10
  67. 67
    Maria P. De Miguel, Sherezade Fuentes-Julián, Yago Alcaina, Pluripotent Stem Cells: Origin, Maintenance and Induction, Stem Cell Reviews and Reports, 2010, 6, 4, 633

    CrossRef

  68. 68
    Francisco Dieguez-Acuña, Shohta Kodama, Yoshiaki Okubo, Ana Cristina Paz, Steven P. Gygi, Denise L. Faustman, Proteomics identifies multipotent and low oncogenic risk stem cells of the spleen, The International Journal of Biochemistry & Cell Biology, 2010, 42, 10, 1651

    CrossRef

  69. 69
    Janka Mátrai, Marinee KL Chuah, Thierry VandenDriessche, Recent Advances in Lentiviral Vector Development and Applications, Molecular Therapy, 2010, 18, 3, 477

    CrossRef

  70. 70
    Patrick Maier, Christof von Kalle, Stephanie Laufs, Retroviral vectors for gene therapy, Future Microbiology, 2010, 5, 10, 1507

    CrossRef

  71. 71
    Caterina Bianco, Maria Cristina Rangel, Nadia P. Castro, Tadahiro Nagaoka, Kelly Rollman, Monica Gonzales, David S. Salomon, Role of Cripto-1 in Stem Cell Maintenance and Malignant Progression, The American Journal of Pathology, 2010, 177, 2, 532

    CrossRef

  72. 72
    Mirella Meregalli, Andrea Farini, Daniele Parolini, Simona Maciotta, Yvan Torrente, Stem Cell Therapies to Treat Muscular Dystrophy, BioDrugs, 2010, 24, 4, 237

    CrossRef

  73. 73
    Vimal Selvaraj, Jennifer M. Plane, Ambrose J. Williams, Wenbin Deng, Switching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologies, Trends in Biotechnology, 2010, 28, 4, 214

    CrossRef

  74. 74
    Wenbo Zhou, Curt R. Freed, Adenoviral Gene Delivery Can Reprogram Human Fibroblasts to Induced Pluripotent Stem Cells, STEM CELLS, 2009, 27, 11
  75. 75
    James O’Malley, Knut Woltjen, Keisuke Kaji, New strategies to generate induced pluripotent stem cells, Current Opinion in Biotechnology, 2009, 20, 5, 516

    CrossRef

  76. 76
    Krishanu Saha, Rudolf Jaenisch, Technical Challenges in Using Human Induced Pluripotent Stem Cells to Model Disease, Cell Stem Cell, 2009, 5, 6, 584

    CrossRef

  77. 77
    Kelly P. Smith, Maria Borowski, Joseph C. Laning, An Introduction to Cellular Reprogramming: The Plasticity of Cell Fates and Identities,
  78. 78
    Tanja Dominko, Cellular Reprogramming: Current Technology, Perspectives, and Generation of Induced Pluripotent Cells,
  79. 79
    Luigi Warren, Jiwu Wang, Feeder-Free Reprogramming of Human Fibroblasts with Messenger RNA, Current Protocols in Stem Cell Biology,
  80. 80
    Christopher C. Ford, Darrell N. Kotton, Human Pluripotent Cells for Regenerative Medicine: Potential Applications for Regenerative Medicine,
  81. 81
    Kejin Hu, Igor Slukvin, Induction of Pluripotent Stem Cells from Umbilical Cord Blood, Encyclopedia of Molecular Cell Biology and Molecular Medicine,
  82. 82
    Gemma L. Mendel, Brian Paszkiet, Rafal P. Witek, Integrating Viral Vectors for Gene Modifications,
  83. 83
    Shigeki Ohta, Ophelia Veraitch, Hideyuki Okano, Manabu Ohyama, Yutaka Kawakami, The Potential of Using Induced Pluripotent Stem Cells in Skin Diseases,